| Literature DB >> 24413763 |
Jiquan Ou1, Zhibin Guo, Jingni Shi, Xianghong Wang, Jingru Liu, Bo Shi, Fengli Guo, Chufu Zhang, Daichnag Yang.
Abstract
Plants provide a promising expression platform for producing recombinant proteins with several advantages in terms of high expression level, lower production cost, scalability, and safety and environment-friendly. Molecular pharming has been recognized as an emerging industry with strategic importance that could play an important role in economic development and healthcare in China. Here, this review represents the significant advances using transgenic rice endosperm as bioreactor to produce various therapeutic recombinant proteins in transgenic rice endosperm and large-scale production of OsrHSA, and discusses the challenges to develop molecular pharming as an emerging industry with strategic importance in China.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24413763 DOI: 10.1007/s00299-013-1559-2
Source DB: PubMed Journal: Plant Cell Rep ISSN: 0721-7714 Impact factor: 4.570